🇺🇸 FDA
Patent

US 11141418

Methods and compositions for KRAS inhibitors

granted A61KA61K31/519

Quick answer

US patent 11141418 (Methods and compositions for KRAS inhibitors) held by The Board of Regents of the University of Texas System expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/519